Welcome to our dedicated page for Aterian SEC filings (Ticker: ATER), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aterian, Inc. filings document material events for a public consumer products company with a portfolio of e-commerce brands and online retail channels. Recent Form 8-K disclosures cover operating results, Regulation FD updates, credit agreement amendments, liquidity covenants, availability reserves, exhibits to material definitive agreements and other capital-structure matters.
The filing record also includes governance and shareholder-vote disclosures, including annual meeting matters, advisory vote frequency decisions, executive compensation voting procedures and officer transition reporting. These filings frame Aterian’s formal disclosures around financial performance, financing arrangements, board and stockholder actions, and corporate strategy updates.
Aterian, Inc. (ATER) reported that Chief Executive Officer and ten percent owner David E. Lazar made several preferred-stock transactions. On July 17, 2026, he acquired 1,750,000 Series AAA Convertible Non-Redeemable Preferred Shares at $2.00 per share, for an aggregate $3,500,000, under an April 27, 2026 Securities Purchase Agreement; each share is convertible, after required stockholder approvals, into 135.1 shares of common stock (up to 236,425,000 common shares) at a conversion price of $0.0148 with no additional consideration and no expiration. Following stockholder approval, on August 4, 2026 he converted Series AA Convertible Non-Redeemable Preferred Stock into 6,737,500 shares of common stock and held 6,737,500 common shares directly afterward. The filing states that these transactions were not made under a Rule 10b5-1 trading plan.
Aterian, Inc. (ATER) discloses that David Elliot Lazar has become its controlling stockholder through a $7.0 million investment in newly created preferred stock. Lazar now beneficially owns 249,900,000 shares of common stock equivalent, representing 95.7% of the outstanding common stock on an as-converted basis.
The ownership arises from a Securities Purchase Agreement under which Lazar bought 1,750,000 Series AA and 1,750,000 Series AAA Convertible Non-Redeemable Preferred shares, together convertible into 249,900,000 common shares. On August 4, 2026, he converted 875,000 Series AA shares into 6,737,500 common shares and retained 875,000 Series AA and all 1,750,000 Series AAA shares.
Lazar is now Chief Executive Officer and Chairperson of the Board and has the right to designate and recommend multiple directors. The preferred stock ranks senior to common in liquidation with at least $2.00 per preferred share, has anti-dilution protections, and typically no general voting rights, but requires majority preferred consent for adverse changes. Lazar states he may pursue further securities transactions and strategic deals, including a potential acquisition of an operating business.
Aterian, Inc. reported very limited continuing operations for the quarter ended June 30, 2026 while preparing for a transformational asset and equity transaction that closed in July. Continuing net revenue was only $7 thousand for the quarter and $25 thousand for the first half of 2026, compared with $88 thousand and $151 thousand in the prior-year periods. Loss from continuing operations was $3.96 million for the quarter and $7.40 million year-to-date, similar to 2025. After income from discontinued operations tied to brands being sold, the company posted a quarterly net loss of $0.49 million and a six‑month net loss of $6.62 million.
As of June 30, 2026, Aterian held $2.55 million in cash and $23.53 million in total assets, including $18.18 million classified as held for sale related to marquee brands being sold to Trademark Global for $18.0 million in cash. The company also completed a preferred stock financing with $7.0 million in aggregate proceeds from investor David E. Lazar, who subsequently became CEO and beneficial owner of about 95.8% of voting securities. Management disclosed that, despite debt repayment and cost reductions, the small scale of the remaining legacy brands and ongoing macro pressures continue to raise substantial doubt about Aterian’s ability to continue as a going concern over the next year.
Aterian, Inc. director Ben-Tzvi Avraham filed an initial statement of beneficial ownership showing he holds 0.0000 shares of the company’s Common Stock. A bound footnote clarifies that no shares of Common Stock are beneficially owned.
Aterian, Inc. director Natan David has filed an initial beneficial ownership report indicating that he does not beneficially own any shares of Aterian common stock. The report lists a holding entry for Common Stock with 0.0000 shares beneficially owned, as confirmed by the attached footnote.
Aterian, Inc. is registering for resale up to 6,737,500 shares of Common Stock issuable upon conversion of 875,000 shares of Series AA Convertible Non-Redeemable Preferred Stock, each convertible into 7.7 Common shares. These are being registered for selling stockholder David Lazar and related permitted transferees; Aterian will not receive proceeds from any resale. The registration follows an April 2026 private placement in which Lazar purchased 1,750,000 Series AA and 1,750,000 Series AAA Preferred shares for $7.0 million total, and an $18 million Asset Sale of marquee brands to Trademark Global, LLC. As of July 17, 2026, 10,879,410 Common shares were outstanding. Full conversion of all preferred series would give Lazar very high ownership and voting power, potentially making Aterian a controlled company and causing substantial dilution to existing holders. The company discloses continued operating losses, a recent going-concern paragraph from its auditor, and substantial doubt about its ability to continue as a going concern.
Aterian, Inc. completed two connected transactions on July 17, 2026: sale of specified consumer-brand assets to Trademark Global, LLC for $18.0 million in cash, and issuance of convertible preferred stock to investor David E. Lazar for aggregate gross proceeds of $7.0 million.
The asset sale covers brands including Mueller Living, PurSteam, hOmeLabs, Squatty Potty, Healing Solutions and Photo Paper Direct, while Aterian retains smaller brands such as Vremi and Xtava. The preferred financing comprised 1,750,000 Series AA and 1,750,000 Series AAA shares at $2.00 per share, each series convertible into common stock at fixed ratios.
Following the second preferred closing, Lazar beneficially owns about 95.8% of Aterian’s issued and outstanding voting securities, constituting a change in control; existing holders collectively own about 4.2% of voting power. Aterian repaid in full all indebtedness under its existing credit agreement and terminated related commitments, guarantees and liens.
The board declared a dividend of non-transferable contingent value rights linked to specified future cash proceeds, with an August 17, 2026 payment date for the dividend, though payments are not assured. Stockholders approved the asset sale, preferred-share conversion-related proposals, a reverse stock split range of 1-for-2 to 1-for-99, and an increase in authorized common shares up to 1,000,000,000.
Aterian, Inc. convened a special stockholder meeting on July 10, 2026 and immediately adjourned it without conducting business. A quorum was present, with 5,278,277 shares, or 48.65% of common stock outstanding as of May 29, 2026, represented virtually or by proxy. The meeting was adjourned because there were not sufficient votes to approve the proposal to sell substantially all of Aterian’s assets to Trademark Global, LLC under an Asset Purchase Agreement dated April 27, 2026. The special meeting will reconvene on July 17, 2026 at 9:30 a.m. Eastern Time via live webcast, with the same record date and unchanged proposals, including the Asset Sale and a related investment transaction with David E. Lazar. Aterian highlights forward-looking statements about these transactions, potential dividends or contingent value rights, and notes risks such as its ability to continue as a going concern, maintain its Nasdaq listing, and meet financial covenants.